Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

111.34
-1.5250-1.35%
Volume:249.25K
Turnover:27.56M
Market Cap:1.63B
PE:-12.54
High:113.95
Open:109.23
Low:107.22
Close:112.86
52wk High:155.29
52wk Low:26.19
Shares:14.67M
Float Shares:8.64M
Volume Ratio:0.44
T/O Rate:2.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.8768
EPS(LYR):-9.0434
ROE:-1773.60%
ROA:-43.61%
PB:-30.83
PE(LYR):-12.31

Loading ...

May 17, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2024

Correspondence

Form CORRESP - Correspondence
Mar 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2024

Major Issues Report

Form 8-K - Current report
Mar 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2024

Major Issues Report

Form 8-K - Current report